Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

United Therapeutics buy Wedbush

Start price
€214.00
02.11.23 / 50%
Target price
€289.92
02.11.24
Performance (%)
59.58%
End price
€341.50
03.11.24
Summary
This prediction ended on 03.11.24 with a price of €341.50. With a performance of 59.58% the BUY prediction by Wedbush was a big success. Wedbush has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
United Therapeutics 1.226% 1.226% 22.100%
iShares Core DAX® 0.734% 1.458% 17.980%
iShares Nasdaq 100 -2.686% -0.146% 3.810%
iShares Nikkei 225® -2.261% -2.729% 11.679%
iShares S&P 500 -1.346% 0.467% 1.970%

Comments by Wedbush for this prediction

In the thread United Therapeutics diskutieren
Prediction Buy
Perf. (%) 59.58%
Target price 289.920
Change
Ends at 02.11.24

United Therapeutics Co. (NASDAQ: UTHR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $308.00 price target on the stock, up previously from $307.00.
Ratings data for UTHR provided by MarketBeat

In the thread Trading United Therapeutics
Prediction Buy
Perf. (%) 59.58%
Target price 289.920
Change
Ends at 02.11.24

Die von Wedbush gewählte maximale Laufzeit wurde überschritten

Stopped prediction by Wedbush for United Therapeutics

buy
United Therapeutics

Start price
Target price
Perf. (%)
€202.00
22.02.24
€284.50
22.02.25
71.78%
23.02.25